|
Target Identification Focused Antibody Phage Display Technique for the Development of Cancer Therapies
Invention Summary:
Immunotherapies are proving to be one of the most effective treatments in oncology, but finding targetable tumor-associated antigens (TAA) or neoantigens remains a major impediment to develop first-in-class pharmaceuticals. Rutgers scientists developed a proteomics-based neoantigen discovery pipeline that simultaneously yields...
Published: 12/8/2021
|
Inventor(s): William Belden
Keywords(s): Antibodies
Category(s): Technology Classifications > Healthcare & Life Sciences
|
